[1]
T. Monmaturapoj, “Differences in Viral Suppression and Renal Safety Effects between Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate”, SRIMEDJ, vol. 31, no. 3, pp. 328–342, Jun. 2016.